Assessment: Botulinum neurotoxin for the treatment of spasticity (An evidence-based review)

Neurology

Volumn 73, Issue 9, 2009, Pages 736-

  Dobkin, Bruce H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; MUSCLE RELAXANT AGENT;

CEREBRAL PALSY; ELECTROMYOGRAM; EVIDENCE BASED PRACTICE; INTERRATER RELIABILITY; LETTER; MOTOR NEURON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SPASTICITY; STROKE; CLINICAL TRIAL (TOPIC); CONVALESCENCE; DRUG EFFECT; EVIDENCE BASED MEDICINE; HUMAN; METHODOLOGY; NOTE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; STANDARD; STATISTICS; TREATMENT OUTCOME; ELECTROMYOGRAPHY; GAIT DISORDER; HEADACHE; MOTONEURON; MYOTATIC REFLEX; TENDON REFLEX; CHEMICALLY INDUCED DISORDER; INNERVATION; MUSCLE WEAKNESS; PATHOLOGICAL REFLEX; REPRODUCIBILITY; SKELETAL MUSCLE;

BOTULINUM TOXINS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME; MOTOR NEURONS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; REFLEX, ABNORMAL; REPRODUCIBILITY OF RESULTS;

EID: 70349305731     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181af0b6e     Document Type: Letter

References (2)

1. DM Simpson J-M Gracies HK Graham Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 70 2008 1691 1698
2. V Dietz T Sinkjaer Spastic movement disorder: impaired reflex function and altered muscle mechanics Lancet Neurol 6 2007 725 733